Tesla shares are on the rise, despite the company's disappointing Q1 results. The electric vehicle giant's stock surged after it announced plans to speed up the launch of new models.
Incyte acquires Escient Pharmaceuticals for $750 million, bolstering its pipeline. Cantor Fitzgerald initiates coverage with a Neutral rating, citing undervaluation concerns despite strong cash flow.
General Motors shares are trading higher on Tuesday after raising its outlook for FY24, following a first-quarter beat. According to Wedbush analyst Daniel Ives, the company is focusing heavily on profitability, with expenses continuing to be a big priority. BofA Securities analyst John Murphy said in a new investor note that there was optimism heading into the quarter.